Literature DB >> 8822207

Activation of the Xenopus oocyte mitogen-activated protein kinase pathway by Mos is independent of Raf.

E K Shibuya1, J Morris, U R Rapp, J V Ruderman.   

Abstract

Synthesis of the protein kinase Mos is required for progesterone-induced activation of MAP kinase, M-phase promoting factor (MPF), and meiotic maturation of Xenopus oocytes. Mos can function as a MAP kinase kinase kinase, leading to activation of MAP kinase; how Mos causes activation of MPF is not yet known. The protein kinase Raf, which acts as a MAP kinase kinase kinase in somatic cells, also appears to be involved in meiotic maturation, but recent work has suggested that the Raf acts downstream of Mos activity during oocyte maturation. Using an oocyte cell-free system, we report here that a dominant negative Raf, which inhibits Ras-induced MAP kinase activation, does not block Mos-induced activation in vitro. These results indicate that, in contrast to previous conclusions, Mos-induced oocyte MAP kinase activation proceeds independently of Raf. Using a dominant-negative MAP kinase construct, we also show that most of the mitogen-induced hyperphosphorylation and dramatic gel retardation of Raf, which is often taken as a marker for the activation of Raf by upstream components, is actually dependent on, and thus downstream of, MAP kinase activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8822207

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

1.  Ajuba, a novel LIM protein, interacts with Grb2, augments mitogen-activated protein kinase activity in fibroblasts, and promotes meiotic maturation of Xenopus oocytes in a Grb2- and Ras-dependent manner.

Authors:  R K Goyal; P Lin; J Kanungo; A S Payne; A J Muslin; G D Longmore
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

2.  Hsp90 is required for c-Mos activation and biphasic MAP kinase activation in Xenopus oocytes.

Authors:  D L Fisher; E Mandart; M Dorée
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

3.  Paxillin and steroid signaling: from frog to human.

Authors:  Stephen R Hammes; Susanne U Miedlich; Aritro Sen
Journal:  Methods Mol Biol       Date:  2014

4.  Activation of the p42 mitogen-activated protein kinase pathway inhibits Cdc2 activation and entry into M-phase in cycling Xenopus egg extracts.

Authors:  J C Bitangcol; A S Chau; E Stadnick; M J Lohka; B Dicken; E K Shibuya
Journal:  Mol Biol Cell       Date:  1998-02       Impact factor: 4.138

5.  The casein kinase II beta subunit binds to Mos and inhibits Mos activity.

Authors:  M Chen; D Li; E G Krebs; J A Cooper
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

6.  The mitogen-activated protein kinase signaling pathway stimulates mos mRNA cytoplasmic polyadenylation during Xenopus oocyte maturation.

Authors:  E L Howard; A Charlesworth; J Welk; A M MacNicol
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

7.  Induction of a G2-phase arrest in Xenopus egg extracts by activation of p42 mitogen-activated protein kinase.

Authors:  S A Walter; T M Guadagno; J E Ferrell
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

8.  The kinase Eg2 is a component of the Xenopus oocyte progesterone-activated signaling pathway.

Authors:  T Andrésson; J V Ruderman
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

9.  Mos 3' UTR regulatory differences underlie species-specific temporal patterns of Mos mRNA cytoplasmic polyadenylation and translational recruitment during oocyte maturation.

Authors:  C Krishna Prasad; Mahendran Mahadevan; Melanie C MacNicol; Angus M MacNicol
Journal:  Mol Reprod Dev       Date:  2008-08       Impact factor: 2.609

10.  Overexpression of hepatocyte nuclear factor-4α initiates cell cycle entry, but is not sufficient to promote β-cell expansion in human islets.

Authors:  Sebastian Rieck; Jia Zhang; Zhaoyu Li; Chengyang Liu; Ali Naji; Karen K Takane; Nathalie M Fiaschi-Taesch; Andrew F Stewart; Jake A Kushner; Klaus H Kaestner
Journal:  Mol Endocrinol       Date:  2012-07-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.